Literature DB >> 12171826

Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease.

Gregory S Ahearn1, Victor F Tapson, Abdallah Rebeiz, Joseph C Greenfield.   

Abstract

STUDY
OBJECTIVES: To determine the utility of the ECG for predicting clinical status in adults with primary pulmonary hypertension (PPH) or pulmonary arterial hypertension (PAH) secondary to collagen vascular disease.
DESIGN: Retrospective study.
SETTING: Outpatient clinic in a tertiary referral center. PATIENTS: Adult outpatients with PPH or PAH secondary to collagen vascular disease who underwent electrocardiography within 30 days of undergoing right-heart catheterization, echocardiography, and 6-min walk testing.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: The following measurements were recorded from each ECG: P-wave amplitude in lead II; mean frontal QRS axis; QRS duration; R-wave and S-wave deflections in leads I and V6; and the T-wave configurations in the precordial leads. These ECG variables were correlated with hemodynamic variables, RV size, and exercise capacity. Of the 61 patients included in this study, 56 (92%) were women. Eight of 61 patients (13%) had normal findings on ECGs. There was no significant difference in the demographics or hemodynamics when comparing groups with normal vs abnormal ECGs. All ECG parameters had no more than moderate correlation with hemodynamic variables, ventricular size measured by echocardiogram, and exercise capacity as measured by a 6-min walk. The best correlation was between mean the frontal QRS axis and cardiac index (r = -0.46).
CONCLUSIONS: The ECG is an inadequate screening tool to rule out the presence of clinically relevant pulmonary hypertension, either primary or secondary to collagen vascular disease. The mean frontal QRS axis correlated best with the severity of hemodynamic impairment.

Entities:  

Mesh:

Year:  2002        PMID: 12171826     DOI: 10.1378/chest.122.2.524

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  Electrocardiographic differences between COPD patients evaluated for lung transplantation with and without pulmonary hypertension.

Authors:  Laith Alkukhun; Manfred Baumgartner; Marie Budev; Raed A Dweik; Adriano R Tonelli
Journal:  COPD       Date:  2014-07-01       Impact factor: 2.409

Review 2.  Management of heart failure with pulmonary hypertension.

Authors:  Mohammed Najeeb Osman; Mark E Dunlap
Journal:  Curr Cardiol Rep       Date:  2005-05       Impact factor: 2.931

3.  QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.

Authors:  Jonathan D Rich; Thenappan Thenappan; Benjamin Freed; Amit R Patel; Ronald A Thisted; Rory Childers; Stephen L Archer
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

4.  Pulmonary arterial hypertension in children: Diagnostic work-up and challenges.

Authors:  E B Rosenzweig; J A Feinstein; T Humpl; D D Ivy
Journal:  Prog Pediatr Cardiol       Date:  2009-12

5.  Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients.

Authors:  Maha K Ghanem; Hoda A Makhlouf; Gamal R Agmy; Hisham M K Imam; Doaa A Fouad
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

6.  Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Laith Alkukhun; Xiao-Feng Wang; Mostafa K Ahmed; Manfred Baumgartner; Marie M Budev; Raed A Dweik; Adriano R Tonelli
Journal:  Respir Med       Date:  2016-06-02       Impact factor: 3.415

7.  Pulmonary hypertension: the role of the electrocardiogram.

Authors:  I R Henkens; R W C Scherptong; K W van Kralingen; S A M Said; H W Vliegen
Journal:  Neth Heart J       Date:  2008-08       Impact factor: 2.380

8.  Electrocardiography at diagnosis and close to the time of death in pulmonary arterial hypertension.

Authors:  Adriano R Tonelli; Manfred Baumgartner; Laith Alkukhun; Omar A Minai; Raed A Dweik
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-12-30       Impact factor: 1.468

9.  Impaired right ventricular function in adenotonsillar hypertrophy.

Authors:  Dursun Duman; Baris Naiboglu; Hande Senem Esen; Sema Zor Toros; Refik Demirtunc
Journal:  Int J Cardiovasc Imaging       Date:  2007-09-06       Impact factor: 2.357

Review 10.  Update on pulmonary hypertension complicating chronic obstructive pulmonary disease.

Authors:  Soma Jyothula; Zeenat Safdar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.